Elevated posaconazole trough concentrations are not associated with increased risk for posaconazole toxicity in lung transplant recipients
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Transplantation"
DOI: 10.1111/ctr.14826
Abstract: Posaconazole is used for prophylaxis and treatment of invasive fungal infections in lung transplant recipients (LTR). Previous studies have not described the relationship between elevated posaconazole trough concentrations and adverse drug reactions in this population. read more here.
Keywords: transplant recipients; lung transplant; elevated posaconazole; trough concentrations ... See more keywords